Breaking News, Promotions & Moves

PL BioScience Taps Oliver Dick as Chief Technology Officer

Dick is an experienced operations executive with over 30 years of experience in project and line management.

Author Image

By: Charlie Sternberg

Associate Editor

PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, has appointed Oliver Dick, PhD, as Chief Technology Officer, a strategic position as the company scales up to meet growing global demand for its animal-free cell culture solutions. “Oliver has an extensive track record in operational excellence and brings a strategic vision as well as hands-on leadership in life sciences and biopharma manufacturin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters